Ondina Cardoni

Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: A comparative study of the efficacy and safety against amlodipine*

L Corea, Ondina Cardoni, Roberto Fogari et al. · Clinical Pharmacology & Therapeutics · 1996 · 135 citations

Metabolic syndrome and left ventricular hypertrophy in a general population. Results from the Gubbio Study

L Ferrara, Ondina Cardoni, Mario Mancini et al. · Journal of Human Hypertension · 2007 · 46 citations

Obesity, Metabolic Syndrome, Cardiomyopathy +13

Indexation Criteria of Ventricular Mass and Predictive Role of Blood Pressure and Body Composition

L Ferrara, Olga Vaccaro, Ondina Cardoni et al. · American Journal of Hypertension · 2005 · 38 citations

Is there a relationship between left ventricular mass and plasma glucose and lipids independent of body mass index? Results of the Gubbio study

Assiamira Ferrara, Olga Vaccaro, Ondina Cardoni et al. · Nutrition Metabolism and Cardiovascular Diseases · 2003 · 26 citations

Metabolic Syndrome, Body Composition, Body Mass Index +9

Combined Therapy with Benazepril and Amlodipine in the Treatment of Hypertension Inadequately Controlled by an ACE Inhibitor Alone

Roberto Fogari, L Corea, Ondina Cardoni et al. · Journal of Cardiovascular Pharmacology · 1997 · 21 citations